Literature DB >> 6967511

An antigen shared by a human T cell subset and B cell chronic lymphocytic leukemic cells. Distribution on normal and malignant lymphoid cells.

L Boumsell, H Coppin, D Pham, B Raynal, J Lemerle, J Dausset, A Bernard.   

Abstract

We obtained a monoclonal antibody, A50, after immunizing Biozzi's high responder strain of mice with T cell chronic lymphocytic leukemia (T-CLL) cells. A50 recognized an antigen present on the surface of B cell chronic lymphocytic leukemia cells from many patients and from cells of T lineage from any subject we tested. We could not find this antigen either on the surface of normal B cell or on other non-T cell malignancies. On T cells, this antigen was present on a subpopulation of thymus cells, and on most peripheral T cells. The antigen was present on the surface of cells from T-CLL, Sézary's disease, and a subset o T cell lymphoma. The antigen seemed to belong to a complex set of antigenic determinants that we had defined with rabbit antisera.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6967511      PMCID: PMC2185910          DOI: 10.1084/jem.152.1.229

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  10 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Serotyping for homotransplantation. 18. Refinement of microdroplet lymphocyte cytotoxicity test.

Authors:  K K Mittal; M R Mickey; D P Singal; P I Terasaki
Journal:  Transplantation       Date:  1968-11       Impact factor: 4.939

3.  Human normal and leukemia cell surface antigens. Mouse monoclonal antibodies as probes.

Authors:  R Levy; J Dilley; L A Lampson
Journal:  Curr Top Microbiol Immunol       Date:  1978       Impact factor: 4.291

4.  Somatic cell genetics of antibody-secreting cells: studies of clonal diversification and analysis by cell fusion.

Authors:  C Milstein; K Adetugbo; N J Cowan; G Köhler; D S Secher; C D Wilde
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1977

5.  Subsets of malignant lymphomas in children related to the cell phenotype.

Authors:  A Bernard; L Boumsell; C Bayle; Y Richard; H Coppin; C Penit; P Rouget; C Micheau; B Clausse; R Gerard-Marchant; J Dausset; J Lemerle
Journal:  Blood       Date:  1979-11       Impact factor: 22.113

6.  Human T cell differentiation antigens and correlation of their expression with various markers of T cell maturation.

Authors:  L Boumsell; A Bernard; H Coppin; Y Richard; C Penit; P Rouget; J Lemerle; J Dausset
Journal:  J Immunol       Date:  1979-11       Impact factor: 5.422

7.  [The value of good Biozzi antibody-producing strains of mice for the production of monoclonal antibodies].

Authors:  L Boumsell; A Bernard
Journal:  C R Seances Acad Sci D       Date:  1979-10-29

8.  A human thymocyte antigen defined by a hybrid myeloma monoclonal antibody.

Authors:  A J McMichael; J R Pilch; G Galfré; D Y Mason; J W Fabre; C Milstein
Journal:  Eur J Immunol       Date:  1979-03       Impact factor: 5.532

9.  Discrete stages of human intrathymic differentiation: analysis of normal thymocytes and leukemic lymphoblasts of T-cell lineage.

Authors:  E L Reinherz; P C Kung; G Goldstein; R H Levey; S F Schlossman
Journal:  Proc Natl Acad Sci U S A       Date:  1980-03       Impact factor: 11.205

10.  Some chronic lymphocytic leukemia cells bearing surface immunoglobulins share determinants with T cells.

Authors:  L Boumsell; A Bernard; V Lepage; L Degos; J Lemerle; J Dausset
Journal:  Eur J Immunol       Date:  1978-12       Impact factor: 5.532

  10 in total
  31 in total

Review 1.  Immune deficiencies in chronic lymphocytic leukemia and multiple myeloma.

Authors:  A Winkelstein; P S Jordan
Journal:  Clin Rev Allergy       Date:  1992 Spring-Summer

2.  Phenotype of chronic lymphocytic leukemia (CLL) B-cells. B-CLL cells express the Leu-8 antigen.

Authors:  A Cafaro; M Napolitano; V Zoli; L Pacilli; I Mezzaroma; A De Laurenzi; F Pandolfi
Journal:  Blut       Date:  1987-01

3.  Phenotypic and functional characterization of human cytolytic T cells lacking expression of CD5.

Authors:  B E Bierer; Y Nishimura; S J Burakoff; B R Smith
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

4.  CD5+ B lymphocytes in systemic lupus erythematosus patients: relation to disease activity.

Authors:  Hanan Hassan Omar; Samah Ismail Nasef; Hamdy Hassan Omar; Mona Sayed Ghaly
Journal:  Clin Rheumatol       Date:  2017-09-16       Impact factor: 2.980

5.  Surface glycoproteins as markers of the cellular status of B chronic lymphocytic leukaemia lymphocytes.

Authors:  V A Brown; S K Smith; A E Dewar; G Stockdill; A H Maddy
Journal:  Clin Exp Immunol       Date:  1985-10       Impact factor: 4.330

6.  The immunological classification of leukaemia based on a rapid microcytotoxicity test.

Authors:  R J Billing; K A Foon; M Linker-Israeli
Journal:  Clin Exp Immunol       Date:  1982-07       Impact factor: 4.330

7.  Antibodies to the CD5 molecule in normal human immunoglobulins for therapeutic use (intravenous immunoglobulins, IVIg).

Authors:  T Vassilev; C Gelin; S V Kaveri; M T Zilber; L Boumsell; M D Kazatchkine
Journal:  Clin Exp Immunol       Date:  1993-06       Impact factor: 4.330

8.  Reactivity of Leu 1 and T101 monoclonal antibodies with B cell lymphomas (correlations with other immunological markers).

Authors:  T Al Saati; G Laurent; P Caveriviere; F Rigal; G Delsol
Journal:  Clin Exp Immunol       Date:  1984-12       Impact factor: 4.330

9.  CD5 acts as a tyrosine kinase substrate within a receptor complex comprising T-cell receptor zeta chain/CD3 and protein-tyrosine kinases p56lck and p59fyn.

Authors:  K E Burgess; M Yamamoto; K V Prasad; C E Rudd
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

10.  Membrane phenotypic studies in B cell lymphoproliferative disorders.

Authors:  C S Scott; H J Limbert; I D MacKarill; B E Roberts
Journal:  J Clin Pathol       Date:  1985-09       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.